Overexpression of Mad transcription factor inhibits proliferation of cultured human hepatocellular carcinoma cells along with tumor formation in immunodeficient animals

Journal of Gene Medicine

Volumn 2, Issue 2, 2000, Pages 117-127

  Gagandeep, S ^a,b   Ott, Michael ^a,c   Nisen, Perry D ^d,e   DePinho, Ronald A ^f,g   Gupta, Sanjeev ^a,f  

^a MARION BESSIN LIVER RESEARCH CENTER   (United States)

^b MARICOPA MEDICAL CENTER   (United States)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF TEXAS AT DALLAS   (United States)

^e ABBOTT LABORATORIES   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Adenovirus; c Myc; Gene therapy; Hepatocellular carcinoma; Mad

Indexed keywords

ADENOVIRIDAE; ANIMALIA;

BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; MAD PROTEIN, MOUSE; MXD1 PROTEIN, HUMAN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

ADENOVIRUS; ANIMAL; ARTICLE; CELL CULTURE; CELL DIVISION; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; INTERPHASE; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY;

ADENOVIRIDAE; ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; DNA-BINDING PROTEINS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTERPHASE; LIVER NEOPLASMS; MICE; MICE, SCID; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0034154747     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-2254(200003/04)2:2<117::aid-jgm96>3.0.co;2-x     Document Type: Article

References (45)

1. Gupta S, Shafritz DA. Viral mechanisms in hepatic oncogenesis. In The Liver: Biology and Pathobiology (3rd edn). Arias IM, Boyer J, Fausto N, Jacoby WR, Schachter D, Shafritz DA (eds). Raven Press Limited: New York, 1994; 1429-1453.
2. Bouchard C, Staller P, Eilers M. Control of cell proliferation by Myc. Trends Cell Biol 1998; 8: 202-206.
3. Peters MA, Sollenberger KG, Kao TL, Taparowsky EJ. A minimal regulatory region maintains constitutive expression of the max gene. Mol Cell Biol 1997; 17: 1037-1048.
4. Yin X, Grove L, Prochownik EV. Lack of transcriptional repression by max homodimers. Oncogene 1998; 16: 2629-2637.
5. Roy AL, Carruthers C, Gutjahr T, Roeder RG. Direct role for Myc in transcription initiation mediated by interactions with TFII-I. Nature 1993; 365: 359-361.
6. Li LH, Nerlov C, Prendergast G, MacGregor D, Ziff EB. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J 1994; 13: 4070-4079.
7. Wu KJ, Polack A, Dalla-Favera R. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science 1999; 283: 676-679.
8. Ayer DE, Kretzner L, Eisenman RN. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 1993; 72: 211-222.
9. Chin L, Schreiber-Agus N, Pellicer I, Chen K, Lee HW, Dudast M, Cordon-Cardo C, DePinho RA. Contrasting roles for Myc and Mad proteins in cellular growth and differentiation. Proc Natl Acad Sci USA 1995; 92: 8488-8492.
10. Cerni C, Bousset K, Seelos C, Burkhardt H, Henriksson M, Luscher B. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. Oncogene 1995; 11: 587-596.
11. Hurlin PJ, Foley KP, Ayer DE, Eisenman RN, Hanahan D, Arbeit JM. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. Oncogene 1995; 11: 2487-2501.
12. Schreiber-Agus N, Chin L, Chen K, Torres R, Rao G, Guida P, Skoultchi AI, DePinho RA. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 1995; 80: 777-786.
13. Harper SE, Qiu Y, Sharp PA. Sin3 corepressor function in Myc-induced transcription and transformation. Proc Natl Acad Sci USA 1996; 93: 8536-8540.
14. Ayer DE, Laherty CD, Lawrence QA, Armstrong AP, Eisenman RN. Mad proteins contain a dominant transcription repression domain. Mol Cell Biol 1996; 16: 5772-5781.
15. Sommer A, Hilfenhaus S, Menkel A, Kremmer E, Seiser C, Loidl P, Luscher B. Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity. Curr Biol 1997; 7: 357-365.
16. Hurlin PJ, Queva C, Koskinen PJ, Steingrimsson E, Ayer DE, Copeland NG, Jenkins NA, Eisenman RN. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J 1995; 14: 5646-5659.
17. Lymboussaki A, Kaipainen A, Hatva E, Vastrik I, Jeskanen L, Jalkanen M, Werner S, Stenback F, Alitalo R. Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin. Br J Cancer 1996; 73: 1347-1355.
18. Cultraro CM, Bino T, Segal S. Function of the c-Myc antagonist Mad1 during a molecular switch from proliferation to differentiation. Mol Cell Biol 1997; 17: 2353-2359.
19. Larsson LG, Bahram F, Burkhardt H, Luscher B. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells. Oncogene 1997; 15: 737-748.
20. Vastrik I, Kaipainen A, Penttila TL, Lymboussakis A, Alitalo R, Parvinen M, Alitalo K. Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro. J Cell Biol 1995; 128: 1197-1208.
21. Queva C, Hurlin PJ, Foley KP, Eisenman RN. Sequential expression of the MAD family of transcriptional repressors during differentiation and development. Oncogene 1998; 16: 967-977.
22. Foley KP, McArthur GA, Queva C, Hurlin PJ, Soriano P, Eisenman RN. Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. EMBO J 1998; 17: 774-785.
23. Schreiber-Agus N, Meng Y, Hoang T, Hou H Jr, Chen K, Greenberg R, Cordon-Cardo C, Lee HW, DePinho RA. Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature 1998; 393: 483-487.
24. Sigal SH, Rajvanshi P, Gorla GR, Saxena R, Sokhi RP, Gebhardt DF Jr, Reid LM, Gupta S. Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events. Am J Physiol 1999; 276: G1260-1272.
25. Roy B, Reisman D. Inducible expression of Mad accelerates growth arrest of serum deprived human glioblastoma cells. Cell Biol Int 1995; 19: 307-313.
26. Chen J, Willingham T, Margraf LR, Schreiber-Agus N, DePinho RA, Nisen PD. Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells. Nat Med 1995; 1: 638-643.
27. Roussel MF, Ashmun RA, Sherr CJ, Eisenman RN, Ayer DE. Inhibition of cell proliferation by the Mad1 transcriptional repressor. Mol Cell Biol 1996; 16: 2796-2801.
28. Gagandeep S, Ott M, Sokhi R, Gupta S. Rapid clearance of syngeneic transplanted hepatocytes following transduction with E-1-deleted adenovirus indicates early host immune responses and offers novel ways for studying viral vector, target cell and host interactions. Gene Ther 1999; 6: 729-736.
29. Ott M, Stockert RJ, Ma Q, Gagandeep S, Gupta S. Simultaneous upregulation of viral receptor expression and DNA synthesis is required for increasing efficiency of retroviral hepatic gene transfer. J Biol Chem 1998; 273: 11954-11961.
30. Gagandeep S, Novikoff PM, Ott M, Gupta S. Paclitaxel shows cytotoxic activity in human hepatocellular carcinoma cell lines. Cancer Lett 1999; 136: 109-118.
31. Gupta S, LaBrecque DR, Shafritz DA. Mitogenic effects of hepatic stimulator substance on cultured nonparenchymal liver epithelial cells. Hepatology 1992; 15: 485-491.
32. Ott M, Rajvanshi P, Sokhi R, Alpini G, Aragona E, Dabeva M, Shafritz DA, Gupta S. Differentiation-specific regulation of transgene expression in a diploid epithelial cell line derived from the normal F344 rat liver. J Pathol 1999; 187: 365-373.
33. Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 1980; 209: 497-499.
34. Nakabayashi H, Taketa K, Miyano M, Yamane T, Sato J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 1982; 42: 3858-3863.
35. Aspinall S, Alexander J, Bos P. Comparative expression of hepatitis B virus antigens in several cell model systems. J Gen Virol 1986; 67: 2315-2323.
36. Gupta S, Parimoo S, Valinluck B, Govindarajan S. C-myc and c-Ha-ras expression and c-Ha-ras polymorphisms in primary hepatocellular carcinoma occur independently of hepatitis B viral DNA integration. Hepatogastroenterology 1992; 39: 188-194. Eur Clin Digest Dis Suppl - Series 1: 184-190.
37. Gupta S, Parimoo S, Valinluck B, Govindarajan S. C-myc and c-Ha-ras expression and c-Ha-ras polymorphisms in primary hepatocellular carcinoma occur independently of hepatitis B viral DNA integration. Hepatogastroenterology 1992; 39: 188-194. Eur Clin Digest Dis Suppl - Series 1: 184-190.
38. Ott M, Rajvanshi P, Sokhi R, Alpini G, Aragona E, Dabeva M, Shafritz DA, Gupta S. Differentiation-specific regulation of transgene expression in a diploid epithelial cell line derived from the normal F344 rat liver. J Pathol 1999; 187: 365-373.
39. Shibuya H, Yoneyama M, Ninomiya-Tsuji J, Matsumoto K, Taniguchi T. IL-2 and EGF receptors stimulate the hemopoeitic cell cycle via different signalling pathways: demonstration of a novel role for c-myc. Cell 1992; 70: 57-67.
40. Waldman T, Lengauer C, Kinzler KW, Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996; 381: 713-716.
41. Waldman T, Zhang Y, Dillehay L, Yu J, Kinzler K, Vogelstein B, Williams J. Cell-cycle arrest versus cell death in cancer therapy. Nat Med 1997; 3: 1034-1036.
42. Gupta S, Gorla GR, Irani AN. Hepatocyte transplantation: emerging insights into mechanisms of liver repopulation and their relevance to potential therapies. J Hepatol 1999; 30: 162-171.
43. Hurlin PJ, Queva C, Eisenman RN. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression of Myc binding sites. Genes Dev 1997; 11: 44-58.
44. Van der Eb MM, Cramer SJ, Vergouwe Y, Schagen FH, van Krieken JH, van der Eb AJ, Rinkes IH, can de Velde CJ, Hoeben RC. Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration. Gene Ther 1998; 5: 451-458.
45. Gagandeep S, Gupta S. Restriction of tumoricidal gene therapy to selected hepatocellular carcinoma cells. Hepatology 1996; 24: 1317-1319.